Jenelle Krishnamoorthy, Vice President and Head of Global Public Policy, Corporate Affairs, Merck & Co.: “Driving Meaningful and Sustained Progress on AMR

Take as Directed

English - November 16, 2023 21:01 - 32 minutes - ★★★★ - 41 ratings
Health & Fitness Government health globalhealth disease healthpolicy policy news csis government cdc usaid Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed

Previous Episode: Dr. Dylan George, Director, CDC Center for Forecasting and Outbreak Analytics (CFA): “We are really looking at the past, when we look up at the sky.”

Next Episode: Heidi Larson, Chair and Co-Founder of the Global Listening Project: “The people part of the Covid experience was our Achilles heel”

In this episode Merck’s Jenelle Krishnamoorthy, a member of the CSIS Bipartisan Alliance for Global Health Security, joins Katherine to discuss the growing challenge of antimicrobial resistance (AMR); the importance of incentivizing research and development of new amicrobials, even as there is pressure to use them in a limited way; plans for a United Nations High-Level Meeting on AMR in 2024; and opportunities to improve funding, governance, and international collaboration to meet the global threat of AMR in the years to come.